Who founded Fountain Therapeutics?

Fountain Therapeutics was founded by Thomas Rando, Joseph Rodgers, Tom Cheung in 2018.

Who are Fountain Therapeutics's investors?

Fountain Therapeutics's investors include Alexandria, Khosla Ventures, Nan Fung Life Sciences, R42 Group.

How much funding has Fountain Therapeutics raised?

Fountain Therapeutics has disclosed $26.9M raised across 3 rounds.

Where is Fountain Therapeutics headquartered?

Fountain Therapeutics is headquartered in San Francisco, US.

Fountain Therapeutics

San Francisco, US · Founded 2018 · Delaware corporation · 4 employees on LinkedIn · 5 known investors

Find your way into Fountain Therapeutics

115 people in our graph share verified history with the Fountain Therapeutics team — schools, employers, funds. One of them is your warm intro.

Chris Rustunlockedknows Tom Cheung · together at University of Colorado Boulder (overlapped)

×10knows the team · via University of Colorado Boulder

knows the team · via The Hong Kong University of Science and Technology

Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates. Its lead programs include a topically applied small-molecule combination to reverse age- and weight-loss-associated skin atrophy and a small-molecule modulator to preserve lean tissue and muscle mass in sarcopenia and GLP agonist-induced atrophy.

Biotech Healthtech Longevity

Founders & leadership

Fountain Therapeutics was founded in 2018 by Thomas Rando, Joseph Rodgers, and Tom Cheung.

Thomas RandoCo-founder

Joseph RodgersinCo-founder

Tom Cheung inCo-founderHe previously led a research group studying the molecular regulation of adult stem cell function during aging.

TsangChief Business Officer

Investors · 5

AlexandriareportedPasadena

Khosla Venturesreported · 2 sourcesMenlo Park · $5K – $50M

Nan Fung Life SciencesreportedHong Kong

R42 GroupreportedSan Francisco

Also in the syndicate · 1

Eli Lilly and Company

Reported raises · per SEC filings

Form D private placements

$26.9M disclosed across 3 rounds · 2018–2021

▶$15.9MraisedDec 2021 · 8 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

William GreeneExecutive Officer, Director
Thomas RandoExecutive Officer, Director
Ashish KhannaDirector
Alex MorganDirector

Offering amount: $15.9M
Amount sold: $15.9M
First sale: Nov 2021
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6MraisedFeb 2020 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Ashish KhannaDirector
Thomas RandoExecutive Officer, Director
John DimosExecutive Officer, Director

Offering amount: $6M
Amount sold: $6M
First sale: Feb 2020
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5MraisedSep 2018 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Thomas A. RandoExecutive Officer, Director, Promoter

Offering amount: $5M
Amount sold: $5M
First sale: May 2018
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Fountain Life14 shared keywordsFountain Life is a private preventive health membership service that uses AI-guided diagnostics, physician-led interpretation, and restorative therapeutics to detect issues early and create personalized plans focused on healthspan and longevity. It offers members always-on access to an integrated care team and an AI medical expert platform (Zori), delivered through clinics located across the United States.

Fountain5 shared keywordsFountain provides an applicant tracking system designed specifically for hiring hourly workers at scale. The platform helps recruiters manage hiring processes from application to first day of work across 75+ countries.

Companies competing with Fountain Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Fountain Life Secures $18M Series B for Longevity Center Expansion - News and Statistics - IndexBoxindexbox.io · Aug 2025

Fountain Therapeutics Announces $15 Million Series A-2 Financingglobenewswire.com · Nov 2021

Anti-Aging Biotech | Raising Capital to Extended Tomorrow - LifeSci Searchlifescisearch.com · Sep 2021

Fountain Therapeutics Closes $6 Million Series A-1 Financingglobenewswire.com · May 2020

Frequently asked questions

What does Fountain Therapeutics do?: Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates. Its lead programs include a topically applied small-molecule combination to reverse age- and weight-loss-associated skin atrophy and a small-molecule modulator to preserve lean tissue and muscle mass in sarcopenia and GLP agonist-induced atrophy.
Who founded Fountain Therapeutics?: Fountain Therapeutics was founded by Thomas Rando, Joseph Rodgers, Tom Cheung in 2018.
Who are Fountain Therapeutics's investors?: Fountain Therapeutics's investors include Alexandria, Khosla Ventures, Nan Fung Life Sciences, R42 Group.
How much funding has Fountain Therapeutics raised?: Fountain Therapeutics has disclosed $26.9M raised across 3 rounds.
Where is Fountain Therapeutics headquartered?: Fountain Therapeutics is headquartered in San Francisco, US.